NCT02610413View on ClinicalTrials.gov

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer

RecruitingOBSERVATIONAL

Enrollment

354

Participants

Timeline

Start Date

March 25, 2014

Primary Completion Date

January 1, 2100

Study Completion Date

January 1, 2100

Conditions

Breast Carcinoma

Interventions

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

02215

RECRUITING

Eastern Cooperative Oncology Group, Boston

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH